China Medical System Holdings Limited
0867
株式のランク
#4687
Established in 1995 and headquartered in North Point, Hong Kong, China Medical... Established in 1995 and headquartered in North Point, Hong Kong, China Medical System Holdings Limited functions as an investment holding company with a primary focus on the development, marketing, and distribution of a wide array of pharmaceutical products throughout the People's Republic of China. The company's extensive portfolio addresses numerous therapeutic areas. Its cardiovascular offerings include Plendil for hypertension and stable angina, XinHuoSu for acute heart failure, and Imdur for coronary heart disease, chronic heart failure, and myocardial infarction prevention. For mental health and neurological support, it provides Deanxit to treat mild-to-moderate depression and anxiety, along with Parlodel tablets for endocrine and neuro system indications. Digestive and liver conditions are managed with products such as Ursofalk for gallstones and cholestatic liver disease, Salofalk for ulcerative colitis and Crohn's disease, Bioflor for diarrhea, Combizym for dyspepsia, and Ganfule capsules for primary liver cancer, plus MOVICOL for chronic constipation. The company also markets Augentropfen Stulln Mono eye drops for senile macula degeneration and asthenopia, Hirudoid for blunt trauma and superficial phlebitis, Elcatonin injection for osteoporosis, and Lamisil tablets for fungal infections. Respiratory issues are addressed by YiNuoShu, while infectious diseases benefit from DanShenTong capsules (for various infections like acne, tonsillitis, and boils) and YinlianQinggan granules for hepatitis. XiDaKang, a protein hydrolysate oral solution, is also part of its offerings. Beyond its pharmaceutical endeavors, the group is also actively involved in agriculture and livestock operations. China Medical System Holdings Limited operates as a subsidiary of Treasure Sea Limited.
株価
$1.33
時価総額
$3.23B
変化（1日）
1.76%
変化（1年）
-22.91%
国
HK
取引 China Medical System Holdings Limited (0867)
カテゴリー
Healthcare
China Medical System Holdings Limited（0867）の利益
Jun 2026 時点の利益 TTM: $309.11M
China Medical System Holdings Limited の最新の財務報告によると、同社の現在の利益は $309.11M です。2023 年には $405.98M の利益を上げ、これは 2022 年の利益 $545.51M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
China Medical System Holdings Limited の利益の推移（2006 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $309.11M | 12.23% |
| 2024 | $275.42M | -32.16% |
| 2023 | $405.98M | -25.58% |
| 2022 | $545.51M | 0.31% |
| 2021 | $543.84M | 26.16% |
| 2020 | $431.08M | 20.66% |
| 2019 | $357.26M | 22.48% |
| 2018 | $291.68M | 4.94% |
| 2017 | $277.96M | 28.62% |
| 2016 | $216.11M | 31.88% |
| 2015 | $163.86M | -10.14% |
| 2014 | $182.36M | 64.80% |
| 2013 | $110.65M | 17.00% |
| 2012 | $94.57M | 39.34% |
| 2011 | $67.87M | 95.03% |
| 2010 | $34.80M | 29.24% |
| 2009 | $26.93M | 37.84% |
| 2008 | $19.54M | 88.74% |
| 2007 | $10.35M | 92.47% |
| 2006 | $5.38M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 470.84% |
IN
|
